Leidos’ (LDOS) Buy Rating Reaffirmed at Cowen
Several other research firms have also weighed in on LDOS. Zacks Investment Research upgraded shares of Leidos from a hold rating to a buy rating and set a $70.00 price objective on the stock in a research note on Friday, November 3rd. Citigroup upped their price objective on shares of Leidos from $65.00 to $71.00 and gave the company a buy rating in a research note on Friday, November 3rd. Stifel Nicolaus reiterated a hold rating and issued a $68.00 price objective on shares of Leidos in a research note on Tuesday, November 21st. TheStreet upgraded shares of Leidos from a c+ rating to a b+ rating in a research note on Monday, October 2nd. Finally, BidaskClub lowered shares of Leidos from a buy rating to a hold rating in a research note on Wednesday, October 18th. Two research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The stock currently has an average rating of Buy and a consensus price target of $68.40.
Leidos (LDOS) opened at $64.74 on Tuesday. The firm has a market cap of $9,862.11, a P/E ratio of 18.01, a price-to-earnings-growth ratio of 1.76 and a beta of 1.69. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.27 and a quick ratio of 1.03. Leidos has a 12 month low of $47.81 and a 12 month high of $65.27.
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Stockholders of record on Monday, December 18th will be paid a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, December 15th. This represents a $1.28 annualized dividend and a dividend yield of 1.98%. Leidos’s dividend payout ratio (DPR) is 63.05%.
In other news, Director John P. Jumper sold 61,212 shares of the stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $64.06, for a total transaction of $3,921,240.72. Following the transaction, the director now owns 306,709 shares in the company, valued at approximately $19,647,778.54. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 1.70% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Leidos by 0.9% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,975 shares of the aerospace company’s stock worth $102,000 after buying an additional 18 shares during the period. Migdal Insurance & Financial Holdings Ltd. boosted its holdings in shares of Leidos by 31.2% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 2,158 shares of the aerospace company’s stock worth $111,000 after buying an additional 513 shares during the period. Bronfman E.L. Rothschild L.P. boosted its holdings in shares of Leidos by 2.0% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 2,191 shares of the aerospace company’s stock worth $113,000 after buying an additional 44 shares during the period. Oppenheimer Asset Management Inc. boosted its holdings in shares of Leidos by 263.0% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 3,111 shares of the aerospace company’s stock worth $161,000 after buying an additional 2,254 shares during the period. Finally, Hanseatic Management Services Inc. bought a new stake in shares of Leidos during the 2nd quarter worth $174,000. 73.48% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “Leidos’ (LDOS) Buy Rating Reaffirmed at Cowen” was first posted by Watch List News and is owned by of Watch List News. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.watchlistnews.com/leidos-ldos-buy-rating-reaffirmed-at-cowen/1774139.html.
Leidos Holdings, Inc (Leidos) is a science and technology solutions company focused on delivering solutions primarily in the areas of national security, health and engineering. The Company is a holding company whose direct 100%-owned subsidiary is Leidos, Inc, which delivers science and technology solutions in the areas of national security, health and engineering to agencies of the United States Department of Defense (DoD), the intelligence community, the United States Department of Homeland Security, and other United States Government civil agencies, state and local government agencies, foreign governments and customers across a variety of commercial markets.
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.